Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,067 | 186 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $1,071 | 62 | $0 (2024) |
| ABBVIE INC. | $394.07 | 27 | $0 (2024) |
| PFIZER INC. | $208.97 | 14 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $152.88 | 13 | $0 (2018) |
| Amgen Inc. | $147.59 | 9 | $0 (2022) |
| Daiichi Sankyo Inc. | $109.91 | 6 | $0 (2019) |
| Allergan, Inc. | $98.41 | 7 | $0 (2022) |
| Boston Scientific Corporation | $86.80 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $70.53 | 4 | $0 (2019) |
| Lilly USA, LLC | $70.44 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $924.51 | 52 | Collegium Pharmaceutical, Inc. ($470.59) |
| 2023 | $671.23 | 38 | Collegium Pharmaceutical, Inc. ($408.50) |
| 2022 | $466.08 | 30 | Collegium Pharmaceutical, Inc. ($158.65) |
| 2021 | $55.58 | 3 | Supernus Pharmaceuticals, Inc. ($22.87) |
| 2020 | $55.73 | 4 | Zyla Life Sciences, Inc. ($25.86) |
| 2019 | $216.73 | 14 | Novartis Pharmaceuticals Corporation ($57.72) |
| 2018 | $642.34 | 44 | ARBOR PHARMACEUTICALS, INC. ($152.88) |
| 2017 | $34.80 | 1 | AtriCure, Inc. ($34.80) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.25 | General |
| Category: Opioid Analgesic | ||||||
| 11/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/21/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: PAIN | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.19 | General |
| Category: Opioid Analgesic | ||||||
| 11/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.07 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $7.00 | General |
| Category: Opioid Analgesic | ||||||
| 10/14/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $23.01 | General |
| Category: Opioid Analgesic | ||||||
| 10/10/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.89 | General |
| Category: Opioid Analgesic | ||||||
| 10/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: PAIN | ||||||
| 10/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.90 | General |
| Category: Opioid Analgesic | ||||||
| 09/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.08 | General |
| Category: NEUROLOGY | ||||||
| 09/12/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.90 | General |
| Category: Opioid Analgesic | ||||||
| 09/09/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $17.67 | General |
| 08/23/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.04 | General |
| Category: Opioid Analgesic | ||||||
| 08/14/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.22 | General |
| Category: Opioid Analgesic | ||||||
| 08/05/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.35 | General |
| Category: Opioid Analgesic | ||||||
| 08/05/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $1.85 | General |
| Category: Opioid Analgesic | ||||||
| 08/01/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.77 | General |
| Category: Opioid Analgesic | ||||||
| 07/24/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.04 | General |
| Category: Opioid Analgesic | ||||||
| 07/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,202 | 1,946 | $588,683 | $110,567 |
| 2022 | 17 | 1,055 | 1,969 | $687,579 | $120,071 |
| 2021 | 16 | 1,609 | 2,454 | $926,905 | $197,830 |
| 2020 | 19 | 1,385 | 2,112 | $582,004 | $111,517 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 289 | 742 | $181,048 | $46,860 | 25.9% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 107 | 167 | $85,504 | $10,804 | 12.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 134 | 173 | $28,718 | $7,480 | 26.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 118 | 150 | $23,400 | $6,355 | 27.2% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 44 | 69 | $36,156 | $5,060 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 54 | 54 | $19,926 | $4,862 | 24.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 65 | 65 | $15,730 | $3,674 | 23.4% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 17 | 18 | $24,480 | $3,081 | 12.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2023 | 77 | 105 | $9,765 | $2,699 | 27.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 54 | 76 | $17,252 | $2,580 | 15.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 24 | 35 | $24,955 | $2,555 | 10.2% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 24 | 28 | $22,680 | $2,049 | 9.0% |
| 64454 | Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | Facility | 2023 | 16 | 35 | $15,225 | $2,012 | 13.2% |
| 64624 | Destruction of nerve branches of knee using imaging guidance | Facility | 2023 | 16 | 19 | $15,732 | $1,999 | 12.7% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 15 | 22 | $12,386 | $1,887 | 15.2% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 17 | 23 | $12,857 | $1,438 | 11.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 31 | 32 | $7,264 | $1,254 | 17.3% |
| 77002 | Fluoroscopic guidance for needle placement | Facility | 2023 | 48 | 64 | $19,520 | $1,231 | 6.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 15 | 22 | $3,872 | $1,152 | 29.8% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 21 | 30 | $10,530 | $1,122 | 10.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 16 | 17 | $1,683 | $415.20 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 314 | 886 | $216,184 | $55,443 | 25.6% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 146 | 254 | $130,048 | $16,783 | 12.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 31 | 37 | $50,320 | $6,771 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 125 | 147 | $24,478 | $6,745 | 27.6% |
About Dr. Rodney Mccarver, MD
Dr. Rodney Mccarver, MD is a Anesthesiology healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831183193.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rodney Mccarver, MD has received a total of $3,067 in payments from pharmaceutical and medical device companies, with $924.51 received in 2024. These payments were reported across 186 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,067).
As a Medicare-enrolled provider, Mccarver has provided services to 5,251 Medicare beneficiaries, totaling 8,481 services with total Medicare billing of $539,985. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Location Little Rock, AR
- Active Since 09/01/2005
- Last Updated 07/08/2007
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1831183193
Products in Payments
- Belbuca (Drug) $855.51
- XTAMPZA (Drug) $215.67
- UBRELVY (Drug) $187.16
- Horizant (Drug) $152.88
- QULIPTA (Drug) $122.73
- Morphabond ER (Drug) $109.91
- BOTOX (Biological) $91.14
- WaveWriter Alpha Prime 16 (Device) $86.80
- Aimovig (Biological) $82.86
- NURTEC ODT (Drug) $81.60
- BOTOX THERAPEUTIC (Biological) $76.60
- LYRICA (Drug) $76.51
- EMGALITY (Drug) $70.44
- AIMOVIG (Biological) $57.72
- PENNSAID (Drug) $43.05
- Symproic (Drug) $41.28
- Senza (Device) $40.36
- AJOVY (Biological) $35.85
- QUTENZA (Drug) $34.90
- ATRICURE ATRICLIP LAA EXCLUSION SYSTEM (Device) $34.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Little Rock
Julio Olaya, M.d, M.D
Anesthesiology — Payments: $22,896
Gregory Smith, M.d, M.D
Anesthesiology — Payments: $15,070
Majid Saleem, Md, MD
Anesthesiology — Payments: $10,579
Dr. Aparna Jindal, Md, MD
Anesthesiology — Payments: $6,860
Ahmed Ghaleb, Md, MD
Anesthesiology — Payments: $6,435
Mr. Mikhail Ivanovsky, Md, MD
Anesthesiology — Payments: $4,564